 |
        
|
COMMENTS: Fosamax Follow-up
Monday, ABC's in-house physician Richard Besser headlined his newscast with an Investigates feature on Merck's Fosamax drug. Prolonged use of the osteoporosis medicine, which is designed to prevent hip fractures by halting bone loss, may make bones brittle, increasing the risk of a broken thigh bone. Now we see Besser following up on the speakerphone with the Food & Drug Administration, suggesting that it notify physicians to be on the lookout for this side effect. "Right now the agency does not feel a warning on this is justified," came the reply.
READER COMMENTS BELOW:
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.
